Skip to main content
. 2000 Aug;66(8):3519–3527. doi: 10.1128/aem.66.8.3519-3527.2000

TABLE 3.

Activities of enzymes involved in the EMP pathway and the pathway leading to the biosynthesis of sugar nucleotides and EPS in cell extracts of the EPS-producing strain S. thermophilus LY03a

Enzyme Avg activity (nmol · mg of cell protein−1 · min−1) ± SD at indicated time point with:
0.22 M lactose
0.15 M lactose + 0.14 M fructose
0.15 M lactose + 0.14 M galactose
0.15 M lactose + 0.14 M glucose
1 2 3 1 2 3 1 2 3 1 2 3
α-Phosphoglucomutase 581 ± 44 829 ± 7 715 ± 18 567 ± 72 717 ± 11 673 ± 30 429 ± 9 603 ± 7 523 ± 20 590 ± 42 897 ± 58 831 ± 6
β-Phosphoglucomutase 0 ± 0 0 ± 0 0 ± 0 0 ± 0 0 ± 0 0 ± 0 0 ± 0 0 ± 0 0 ± 0 0 ± 0 0 ± 0 0 ± 0
UDP-glucose pyrophosphorylase 137 ± 11 199 ± 2 175 ± 5 147 ± 21 171 ± 3 161 ± 8 108 ± 2 155 ± 8 142 ± 11 148 ± 11 224 ± 14 208 ± 2
UDP-galactose 4-epimerase 281 ± 60 396 ± 38 351 ± 44 252 ± 39 297 ± 6 277 ± 14 183 ± 4 275 ± 15 258 ± 16 277 ± 18 410 ± 25 382 ± 3
dTDP-glucose pyrophosphorylase 0 ± 0 0 ± 0 0 ± 0 0 ± 0 0 ± 0 0 ± 0 0 ± 0 2 ± 1 1 ± 0 1 ± 1 3 ± 1 1 ± 0
Dehydratase 15 ± 1 20 ± 1 14 ± 2 8 ± 1 12 ± 1 8 ± 2 30 ± 2 36 ± 3 25 ± 1 18 ± 3 31 ± 1 17 ± 1
Epimerase reductase 0 ± 0 2 ± 1 1 ± 1 0 ± 0 2 ± 1 0 ± 0 0 ± 0 2 ± 0 0 ± 1 0 ± 0 2 ± 0 0 ± 0
Phosphoglucose isomerase 1,635 ± 253 2,034 ± 327 1,984 ± 76 2,167 ± 225 2,167 ± 294 2,061 ± 321 1,371 ± 197 1,496 ± 53 1,467 ± 50 2,084 ± 26 2,523 ± 103 2,112 ± 256
6-Phosphofructokinase 1,832 ± 100 2,478 ± 148 2,444 ± 270 2,239 ± 230 2,425 ± 90 2,306 ± 154 1,778 ± 161 1,830 ± 65 1,795 ± 61 2,132 ± 27 2,582 ± 106 2,161 ± 262
Fructose 1,6-bisphosphatase 0 ± 0 0 ± 0 0 ± 0 0 ± 0 0 ± 0 0 ± 0 0 ± 0 0 ± 0 0 ± 0 3 ± 3 20 ± 3 1 ± 1
a

S. thermophilus LY03 was grown in batch cultures in MRS broth on lactose and combinations of lactose and glucose, lactose and galactose, and lactose and fructose as carbohydrate sources at 42°C and a constant pH of 6.2. Samples were taken at three time points of the fermentation course, representing the exponential growth phase (point 1), the end of the exponential growth phase (point 2), and the stationary phase (point 3). Each value is the average of at least three measurements. 

HHS Vulnerability Disclosure